Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.40
Delayed Data
As of Feb 23
 +0.04 / +1.69%
Today’s Change
1.20
Today|||52-Week Range
6.24
+45.45%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.003.2M145.0K
 
 
 
Depreciation And Amortization353.0K344.0K285.0K266.0K
 
 
 
 
 
 
Operating ExpensesGross Income-353.0K-344.0K----
 
 
 
General Expenses27.9M28.1M40.8M57.3M
 
 
 
 
 
Research And Development21.7M21.8M33.5M46.5M
 
 
 
 
 
Total Operating Expenses28.2M28.5M41.1M57.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.2M-28.5M-37.9M-57.4M
 
 
 
 
 
Extraordinary Credit0.000.000.001.7M
 
 
Interest Expense On Debt2.6M1.0M0.000.00
 
 
 
Other Expenses-15.0K-96.0K2.7M171.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.9M-29.6M-35.2M-55.5M
 
 
 
 
 
Preferred Dividend0.000.000.00-10.9M
 
 
Net Income-30.9M-29.6M-35.2M-55.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.3M2.7M4.5M5.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.3M2.7M4.5M5.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.52-$10.88-$7.92-$12.88
 
 
 
 
 
EPS Diluted-$13.52-$10.88-$7.92-$12.88